These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27089454)

  • 1. Skin Barrier Defects Caused by Keratinocyte-Specific Deletion of ADAM17 or EGFR Are Based on Highly Similar Proteome and Degradome Alterations.
    Tholen S; Wolf C; Mayer B; Knopf JD; Löffek S; Qian Y; Kizhakkedathu JN; Biniossek ML; Franzke CW; Schilling O
    J Proteome Res; 2016 May; 15(5):1402-17. PubMed ID: 27089454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C γ1 and protein kinase C pathways.
    Wolf C; Qian Y; Brooke MA; Kelsell DP; Franzke CW
    Sci Rep; 2016 Dec; 6():39780. PubMed ID: 28004780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
    Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
    J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.
    Shimoda M; Horiuchi K; Sasaki A; Tsukamoto T; Okabayashi K; Hasegawa H; Kitagawa Y; Okada Y
    EBioMedicine; 2016 Mar; 5():114-24. PubMed ID: 27077118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinase 10 Degradomics in Keratinocytes and Epidermal Tissue Identifies Bioactive Substrates With Pleiotropic Functions.
    Schlage P; Kockmann T; Sabino F; Kizhakkedathu JN; Auf dem Keller U
    Mol Cell Proteomics; 2015 Dec; 14(12):3234-46. PubMed ID: 26475864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17.
    Liu J; Zhu G; Jia N; Wang W; Wang Y; Yin M; Jiang X; Huang Y; Zhang J
    Int J Biol Sci; 2019; 15(2):493-506. PubMed ID: 30745837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR inhibitors switch keratinocytes from a proliferative to a differentiative phenotype affecting epidermal development and barrier function.
    Joly-Tonetti N; Ondet T; Monshouwer M; Stamatas GN
    BMC Cancer; 2021 Jan; 21(1):5. PubMed ID: 33402117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.
    Shipman WD; Chyou S; Ramanathan A; Izmirly PM; Sharma S; Pannellini T; Dasoveanu DC; Qing X; Magro CM; Granstein RD; Lowes MA; Pamer EG; Kaplan DH; Salmon JE; Mehrara BJ; Young JW; Clancy RM; Blobel CP; Lu TT
    Sci Transl Med; 2018 Aug; 10(454):. PubMed ID: 30111646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras.
    Dlugosz AA; Hansen L; Cheng C; Alexander N; Denning MF; Threadgill DW; Magnuson T; Coffey RJ; Yuspa SH
    Cancer Res; 1997 Aug; 57(15):3180-8. PubMed ID: 9242447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
    Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
    Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
    Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer.
    Mustafi R; Dougherty U; Mustafi D; Ayaloglu-Butun F; Fletcher M; Adhikari S; Sadiq F; Meckel K; Haider HI; Khalil A; Pekow J; Konda V; Joseph L; Hart J; Fichera A; Li YC; Bissonnette M
    Clin Cancer Res; 2017 Jan; 23(2):549-561. PubMed ID: 27489286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
    Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
    J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
    Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
    Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte growth factor receptor ligands induce transforming growth factor alpha expression and activate the epidermal growth factor receptor signaling pathway in cultured epidermal keratinocytes.
    Dlugosz AA; Cheng C; Denning MF; Dempsey PJ; Coffey RJ; Yuspa SH
    Cell Growth Differ; 1994 Dec; 5(12):1283-92. PubMed ID: 7535082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa.
    Rademacher F; Simanski M; Schröder L; Mildner M; Harder J
    Exp Dermatol; 2017 Mar; 26(3):227-233. PubMed ID: 27513608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
    Murthy A; Shao YW; Narala SR; Molyneux SD; Zúñiga-Pflücker JC; Khokha R
    Immunity; 2012 Jan; 36(1):105-19. PubMed ID: 22284418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
    Sahin U; Blobel CP
    FEBS Lett; 2007 Jan; 581(1):41-4. PubMed ID: 17169360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
    Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The shedding protease ADAM17: Physiology and pathophysiology.
    Zunke F; Rose-John S
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2059-2070. PubMed ID: 28705384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.